$LMAT
LEMAITRE VASCULAR INC

2015 Q4 Form 10-Q Financial Statement

#000119312515369622 Filed on November 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $20.48M $19.03M $17.50M
YoY Change 9.65% 8.71% 14.39%
Cost Of Revenue $6.080M $5.509M $5.498M
YoY Change 3.93% 0.2% 19.94%
Gross Profit $14.40M $13.52M $12.00M
YoY Change 12.28% 12.61% 12.01%
Gross Profit Margin 70.32% 71.04% 68.58%
Selling, General & Admin $9.360M $8.944M $8.856M
YoY Change 10.51% 0.99% 4.35%
% of Gross Profit 64.99% 66.17% 73.78%
Research & Development $1.580M $1.421M $1.109M
YoY Change 46.3% 28.13% -14.69%
% of Gross Profit 10.97% 10.51% 9.24%
Depreciation & Amortization $890.0K $830.0K $800.0K
YoY Change -2.2% 3.75% 11.11%
% of Gross Profit 6.18% 6.14% 6.67%
Operating Expenses $11.31M $10.20M $10.15M
YoY Change 13.1% 0.43% 2.12%
Operating Profit $3.093M $3.321M $1.852M
YoY Change 9.37% 79.32% 138.66%
Interest Expense $50.00K -$180.0K $6.000K
YoY Change -200.0% -3100.0% 0.0%
% of Operating Profit 1.62% -5.42% 0.32%
Other Income/Expense, Net
YoY Change
Pretax Income $3.140M $3.139M $1.899M
YoY Change 16.73% 65.3% 141.91%
Income Tax $610.0K $1.047M $965.0K
% Of Pretax Income 19.43% 33.35% 50.82%
Net Earnings $2.530M $2.092M $934.0K
YoY Change 32.05% 123.98% 29.54%
Net Earnings / Revenue 12.35% 11.0% 5.34%
Basic Earnings Per Share $0.14 $0.12 $0.05
Diluted Earnings Per Share $0.13 $0.11 $0.05
COMMON SHARES
Basic Shares Outstanding 18.12M shares 17.87M shares 17.35M shares
Diluted Shares Outstanding 18.50M shares 17.71M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.50M $23.60M $18.40M
YoY Change 47.06% 28.26% 35.29%
Cash & Equivalents $27.45M $23.63M $18.35M
Short-Term Investments
Other Short-Term Assets $3.600M $3.100M $3.600M
YoY Change 50.0% -13.89% 16.13%
Inventory $15.21M $15.92M $16.93M
Prepaid Expenses
Receivables $11.97M $11.34M $10.59M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $58.18M $53.98M $49.43M
YoY Change 19.75% 9.19% 26.63%
LONG-TERM ASSETS
Property, Plant & Equipment $7.022M $6.788M $7.196M
YoY Change 2.09% -5.67% 20.25%
Goodwill $17.79M $17.72M $17.44M
YoY Change 2.94% 1.58% 16.03%
Intangibles $6.336M $6.656M $7.635M
YoY Change -11.47% -12.82% 24.61%
Long-Term Investments
YoY Change
Other Assets $168.0K $168.0K $174.0K
YoY Change -1.18% -3.45% 10.13%
Total Long-Term Assets $32.52M $32.64M $34.07M
YoY Change -1.17% -4.2% 23.62%
TOTAL ASSETS
Total Short-Term Assets $58.18M $53.98M $49.43M
Total Long-Term Assets $32.52M $32.64M $34.07M
Total Assets $90.70M $86.61M $83.50M
YoY Change 11.3% 3.73% 25.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.366M $931.0K $1.021M
YoY Change 21.21% -8.81% 36.5%
Accrued Expenses $8.837M $7.598M $8.670M
YoY Change 18.16% -12.36% 17.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.37M $8.833M $12.58M
YoY Change 3.26% -29.79% 35.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $774.0K $676.0K $400.0K
YoY Change 138.15% 69.0% 64.61%
Total Long-Term Liabilities $774.0K $676.0K $400.0K
YoY Change 138.15% 69.0% 64.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.37M $8.833M $12.58M
Total Long-Term Liabilities $774.0K $676.0K $400.0K
Total Liabilities $12.82M $12.43M $16.38M
YoY Change -3.5% -24.14% 46.21%
SHAREHOLDERS EQUITY
Retained Earnings $8.161M $6.356M $1.332M
YoY Change 151.26% 377.18% -194.27%
Common Stock $197.0K $195.0K $188.0K
YoY Change 4.79% 3.72% 11.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.519M $8.520M $8.253M
YoY Change 3.22% 3.24% 3.12%
Treasury Stock Shares 1.431M shares 1.431M shares 1.407M shares
Shareholders Equity $77.88M $74.19M $67.12M
YoY Change
Total Liabilities & Shareholders Equity $90.70M $86.61M $83.50M
YoY Change 11.3% 3.73% 25.38%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $2.530M $2.092M $934.0K
YoY Change 32.05% 123.98% 29.54%
Depreciation, Depletion And Amortization $890.0K $830.0K $800.0K
YoY Change -2.2% 3.75% 11.11%
Cash From Operating Activities $3.930M $4.210M $2.900M
YoY Change 46.64% 45.17% 21.34%
INVESTING ACTIVITIES
Capital Expenditures -$730.0K -$770.0K -$220.0K
YoY Change 78.05% 250.0% -45.0%
Acquisitions
YoY Change
Other Investing Activities -$140.0K $200.0K -$5.390M
YoY Change -85.71% -103.71% 69.5%
Cash From Investing Activities -$860.0K -$570.0K -$5.610M
YoY Change -38.13% -89.84% 56.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 850.0K 580.0K -2.160M
YoY Change -207.59% -126.85% 1100.0%
NET CHANGE
Cash From Operating Activities 3.930M 4.210M 2.900M
Cash From Investing Activities -860.0K -570.0K -5.610M
Cash From Financing Activities 850.0K 580.0K -2.160M
Net Change In Cash 3.920M 4.220M -4.870M
YoY Change 684.0% -186.65% 255.47%
FREE CASH FLOW
Cash From Operating Activities $3.930M $4.210M $2.900M
Capital Expenditures -$730.0K -$770.0K -$220.0K
Free Cash Flow $4.660M $4.980M $3.120M
YoY Change 50.81% 59.62% 11.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18116429 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1644500 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.00
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1628000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18354000
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1431139 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19499818 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1926000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4539000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
74186000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
676000
CY2015Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
476000
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
80188000
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7069000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
931000
CY2015Q3 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
2500000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
253000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7598000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6356000
CY2015Q3 us-gaap Liabilities
Liabilities
12426000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86612000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
195000
CY2015Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
657000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8833000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4033000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2917000
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3269000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168000
CY2015Q3 us-gaap Assets
Assets
86612000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1012000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1199000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6656000
CY2015Q3 us-gaap Inventory Net
InventoryNet
15920000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11339000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
365000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6788000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
68207000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
325000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
496000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1456000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
578000
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8520000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
53977000
CY2015Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13725000
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9776000
CY2015Q3 us-gaap Goodwill
Goodwill
17717000
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2875000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3089000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23629000
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1306000
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
827000
CY2015Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
1000000
CY2015Q3 lmat Acquisition Related Obligations
AcquisitionRelatedObligations
304000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14711000
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1407211 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
37000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18778436 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1720000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4819000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75389000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6312000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1127000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
242000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7479000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3248000
CY2014Q4 us-gaap Liabilities
Liabilities
13285000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81492000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
188000
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
444000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10041000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2365000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2919000
CY2014Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10500000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2830000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
228000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.452 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.018 pure
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3367000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
170000
CY2014Q4 us-gaap Assets
Assets
81492000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7157000
CY2014Q4 us-gaap Inventory Net
InventoryNet
16714000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10803000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6878000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8253000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
48588000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13469000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9883000
CY2014Q4 us-gaap Goodwill
Goodwill
17281000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3464000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2379000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18692000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1418000
CY2014Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
800000
CY2014Q4 lmat Acquisition Related Obligations
AcquisitionRelatedObligations
1435000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
414000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.105
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16772000 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
175000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16358000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
774000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
28000
us-gaap Net Income Loss
NetIncomeLoss
1999000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1375000
us-gaap Sales Revenue Net
SalesRevenueNet
52416000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1700000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
518000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10834000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
403000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
211000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5577000
us-gaap Operating Income Loss
OperatingIncomeLoss
3601000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2488000
us-gaap Gross Profit
GrossProfit
35603000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
194000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1375000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
30000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1133000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
366000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
624000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1375000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3627000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1276000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1628000
us-gaap Share Based Compensation
ShareBasedCompensation
982000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16857000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3643000
us-gaap Operating Expenses
OperatingExpenses
32002000
us-gaap Restructuring Charges
RestructuringCharges
500000
us-gaap Interest Expense
InterestExpense
6000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6360000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7452000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3590000
us-gaap Inventory Write Down
InventoryWriteDown
508000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10376000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-279000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
28000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1098000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
16813000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-304000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2422000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000
lmat Common Stock Repurchased For Restricted Stock Unit Tax Withholdings
CommonStockRepurchasedForRestrictedStockUnitTaxWithholdings
211000
lmat Accrued Contingent Earn Out
AccruedContingentEarnOut
138000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
7513000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17625000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-11-20
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y3M18D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001158895
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.286 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.014 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
510000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.120
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
LEMAITRE VASCULAR INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18136000 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
721000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.80
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.32
dei Trading Symbol
TradingSymbol
LMAT
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-12-04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1558000
us-gaap Net Income Loss
NetIncomeLoss
5228000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1668000
us-gaap Sales Revenue Net
SalesRevenueNet
57869000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2120000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
791000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
266000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1426000
us-gaap Operating Income Loss
OperatingIncomeLoss
8424000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
360000
us-gaap Gross Profit
GrossProfit
39763000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1078000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1668000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-142000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1100000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3560000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1668000
us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8289000
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3341000
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
49000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-130000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4937000
us-gaap Operating Expenses
OperatingExpenses
31339000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3061000
us-gaap Share Based Compensation
ShareBasedCompensation
1088000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
360000
us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16866000
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2615000
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-306000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
232000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3904000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
554000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3718000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
15000
us-gaap Inventory Write Down
InventoryWriteDown
462000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10375000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-193000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1135000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
18106000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
214000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2497000
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
156000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
742000
lmat Statute Of Limitation Expiration Period
StatuteOfLimitationExpirationPeriod
Until 2024
lmat Common Stock Repurchased For Restricted Stock Unit Tax Withholdings
CommonStockRepurchasedForRestrictedStockUnitTaxWithholdings
266000
lmat Purchase Commitments Inventory Expire Year
PurchaseCommitmentsInventoryExpireYear
2017
CY2014Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.10 pure
CY2014Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
7 Employees
CY2014Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
100000
CY2014Q1 us-gaap Severance Costs1
SeveranceCosts1
400000
CY2014Q2 us-gaap Severance Costs1
SeveranceCosts1
100000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
356000 shares
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
361000 shares
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.035
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
8000
CY2014Q3 us-gaap Interest Expense
InterestExpense
6000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1109000
CY2014Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
178000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3765000
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
359000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17709000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17348000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
934000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1378000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
17501000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1852000
CY2014Q3 us-gaap Gross Profit
GrossProfit
12003000
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
52000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-444000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1378000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1899000
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
965000
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
439000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5091000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
10151000
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5498000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40000 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
632000 shares
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.040
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18497000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17865000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
2092000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-508000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
19025000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3321000
CY2015Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
360000
CY2015Q3 us-gaap Gross Profit
GrossProfit
13516000
CY2015Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-185000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1584000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-508000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3139000
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1047000
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
479000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5489000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
10195000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1421000
CY2015Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
190000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3455000
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
387000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5509000

Files In Submission

Name View Source Status
0001193125-15-369622-index-headers.html Edgar Link pending
0001193125-15-369622-index.html Edgar Link pending
0001193125-15-369622.txt Edgar Link pending
0001193125-15-369622-xbrl.zip Edgar Link pending
d14917d10q.htm Edgar Link pending
d14917dex311.htm Edgar Link pending
d14917dex312.htm Edgar Link pending
d14917dex321.htm Edgar Link pending
d14917dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lmat-20150930.xml Edgar Link completed
lmat-20150930.xsd Edgar Link pending
lmat-20150930_cal.xml Edgar Link unprocessable
lmat-20150930_def.xml Edgar Link unprocessable
lmat-20150930_lab.xml Edgar Link unprocessable
lmat-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending